NSE filing, NSE: QLINE. Summary written from the filing by ALFA Finder's alert engine.
Q-Line Biotech Ltd: key numbers
- Share price
- ₹525.05
- Market cap
- ₹1,225 Cr
- Revenue (annual)
- ₹341.7 Cr
- Net profit (annual)
- ₹55.72 Cr
- P/E (TTM)
- 22.0×Sector 52.3×
- Promoter holding
- 67.51%
- FII holding
- 0.87%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Q-Line Biotech Ltd
All →Q-Line Biotech Annual General Meeting
Q-Line Biotech Limited held its 16th Annual General Meeting on September 30, 2026. The meeting transacted ordinary and special business, including financial statement adoption and director re-appointments.
Q-Line Biotech Annual General Meeting
Q-Line Biotech has sent a letter to shareholders with bounced emails, providing links to the Annual Report and 16th AGM Notice, scheduled for September 30, 2026.
Q-Line Biotech Annual Report
Q-Line Biotech Limited has submitted its Annual Report for the financial year 2025-26. The full document is accessible via the provided company website link.
Q-Line Biotech Board Meeting Outcome
Q-Line Biotech approved the Board's Report, notice for the 16th AGM, and re-appointment of two Whole Time Directors and the Cost Auditor.
Q-Line Biotech Other Announcement
Q-Line Biotech Limited has re-appointed M/s. P S P & Associates as Cost Auditors for a 12-month term.
- Execution
- 12 months
Q-Line Biotech Partnership
Q-Line Biotech amended its license agreement with Boule Medical AB, Sweden. The revision includes a 25% reduction in license/royalty costs effective from July 2026.
- From
- Boule Medical AB
- Execution
- 5 years
Other board meeting date announcements
All →Gokaldas Exports Board Meeting Date
Gokaldas Exports schedules a board meeting on 5 November 2026 to consider unaudited standalone and consolidated results. The trading window remains closed until 48 hours after results declaration.
Bhilwara Technical Textiles Board Meeting Date
Bhilwara Technical Textiles schedules a board meeting on 6 November 2026 to consider unaudited results. Trading window stays closed until 8 November 2026.
Prime Securities Board Meeting Date
Prime Securities will hold a board meeting on November 12, 2026 to approve unaudited results. Results cover the quarter and half year ended September 30, 2026.
Integrated Proteins Board Meeting Date
Integrated Proteins will hold a board meeting on November 5, 2026 to approve unaudited results for the quarter and half year ended September 30, 2026. The trading window reopens on November 7, 2026.
Vardhman Polytex Board Meeting Date
Vardhman Polytex will hold a board meeting on November 12, 2026 to approve September quarter results. The trading window stays closed until 48 hours after declaration.
Kusumgar Board Meeting Date
KUSUMGAR LIMITED has given prior intimation of a board meeting on 05 Nov 2026 to consider unaudited standalone and consolidated half-yearly financial results for the period ended September 2026. Trading window closes 01-10-2026 to 07-11-2026.